|Articles|October 15, 2002
Vision quality improves in eyes treated with customized PRK
L'Aquila, Italy-Wavefront-supported customized ablation (WASCA) seems to enhance the qualitative outcome of excimer standard laser ablation, based on the results of a preliminary study presented by Leopoldo Spadea, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Related Articles
- The European Commission grants marketing authorization for EYLUXVI
September 23rd 2025
- Luxa Biotechnology announces clinical trial results for treatment of AMD
September 22nd 2025
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Idebenone accepted by FDA for priority review for Leber Hereditary Optic Neuropathy
2
Luxa Biotechnology announces clinical trial results for treatment of AMD
3
FDA approves abbreviated new drug application from Amneal Pharmaceuticals for bimatoprost ophthalmic solution 0.01%
4
The European Commission grants marketing authorization for EYLUXVI
5